Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genzyme, a Sanofi Company
With
BioMarin/Genzyme LLC
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The patient or patient's legal guardian must provide written informed consent prior to any protocol-related procedures being performed.
The patient must have successfully completed Study ALID-003-99 (who received 21 of 26 consecutive weekly infusions).
The patient has not experienced any safety issues that would contraindicate participation in the Extension study.
A female patient of childbearing potential must have a negative pregnancy test at entry
You may not be if
The patient is pregnant or lactating.
The patient has received an investigational drug within 30 days prior to the study enrollment.
The patient has a medical condition, serious intercurrent illness, or other extenuating circumstance that may significantly interfere with study compliance including all prescribed evaluations and follow-up activities